Pre-market hot trades in US stocks: Locafy up 14.25% in pre-market
I'm LongbridgeAI, I can summarize articles.Locafy pre-market up 14.25%; Endra Life Sciences pre-market up 142.72%; Bolt Projects pre-market up 35.20%; Biosig Tech pre-market up 33.33%
Pre-market Hot Trades in US Stocks
Locafy pre-market up 14.25%. Based on recent important news:
-
On July 7, Locafy launched a new AI search platform, enhancing visibility for businesses in organic and AI search, driving the stock price up 14.25%.
-
On July 7, Locafy announced its mission to revolutionize the $700 billion SEO industry, attracting investor attention.
-
On July 8, Trump's tariff policy may affect overall market sentiment, but Locafy benefits from its technological innovations.
Top Gainers in US Pre-market Trading
ENDRA Life Sciences pre-market up 142.72%. Based on recent important news:
-
On May 16, analysts rated ENDRA Life Sciences as "Strong Buy," with a target price of $50, significantly boosting the stock price.
-
On May 21, the innovative drug sector rose overall, driving up ENDRA Life Sciences' stock price.
-
On May 23, the pharmaceutical sector performed strongly, further pushing up ENDRA Life Sciences' stock price.
Bolt Projects pre-market up 35.20%. Based on recent important news:
-
On May 12, Bolt Projects announced its Q1 2025 financial report, expecting at least $4.5 million in revenue for 2025 and at least $9 million for 2026, driving the stock price up 35.20%.
-
On May 30, Golden Arrow Sponsor, LLC sold 50,000 shares of Bolt Projects for $154,480, causing stock price fluctuations.
-
On May 13, Bolt Projects disclosed its financial performance in Berkeley, California, emphasizing strong customer repeat order rates and continuously expanding sales prospects, further solidifying its market position.
Biosig Tech pre-market up 33.33%. Based on recent important news:
-
On July 7, BioSig Technologies announced a merger with Streamex Exchange and signed a financing agreement of up to $1.1 billion, driving the commodity market on-chain, resulting in a stock price surge of 33.33%.
-
On July 7, the company plans to raise funds through convertible bonds and equity credit lines, further promoting gold-backed investment strategies.
-
On July 7, BioSig's strategic transformation aims to seize significant opportunities in the commodity market and enhance market confidence
